Inhibitor Therapeutics, Inc. (INTI) › Net IncomeInhibitor Therapeutics, Inc. (INTI) — Net IncomeAnnual figures by fiscal year, from SEC filings.2012: $186.4K2013: -$1.84M2014: -$3.98M2015: -$3.95M2016: -$7.00M2017: -$5.10M2018: -$4.55M2019: -$2.73M2020: -$1.06M2021: -$298.6K2022: $12.11M2023: -$3.03M2024: -$3.34M2025: -$3.30M-$3.30M2012Net Income (USD)2025Fiscal YearNet IncomeChange YoY2025-$3.30M+1.2%2024-$3.34M-10.3%2023-$3.03M-125.0%2022$12.11M+4153.9%2021-$298.6K+71.8%2020-$1.06M+61.3%2019-$2.73M+39.9%2018-$4.55M+10.8%2017-$5.10M+27.1%2016-$7.00M-77.2%2015-$3.95M+0.6%2014-$3.98M-116.6%2013-$1.84M-1084.7%2012$186.4K—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share